CAGE-seq reveals that HIV-1 latent infection does not trigger unique cellular responses in a Jurkat T cell model.
Autor: | Matsui H; From the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Shirakawa K; From the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan kotash@kuhp.kyoto-u.ac.jp., Konishi Y; From the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Hematology, Kansai Electric Power Medical Research Institute, Osaka, Japan., Hirabayashi S; From the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., Sarca AD; From the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Fukuda H; From the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Nomura R; From the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Stanford E; From the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Horisawa Y; From the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Kazuma Y; From the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Matsumoto T; From the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Yamazaki H; From the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Murakawa Y; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.; Institute for the advanced study of human biology, Kyoto University, Kyoto, Japan.; Department of Medical Systems Genomics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; The FIRC Institute of Molecular Oncology (IFOM), Milan, Italy., Battivelli E; Buck Institute for Research on Aging, Novato, CA, USA., Verdin E; Buck Institute for Research on Aging, Novato, CA, USA., Koyanagi Y; Laboratory of Systems Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan., Takaori-Kondo A; From the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of virology [J Virol] 2021 Mar 25; Vol. 95 (8). Date of Electronic Publication: 2021 Jan 27. |
DOI: | 10.1128/JVI.02394-20 |
Abstrakt: | The cure for HIV-1 is currently stalled by our inability to specifically identify and target latently infected cells. HIV-1 viral RNA/DNA or viral proteins are recognized by cellular mechanisms and induce interferon responses in virus producing cells, but changes in latently infected cells remain unknown. HIV (Copyright © 2021 Matsui et al.) |
Databáze: | MEDLINE |
Externí odkaz: |